Reducing low density lipoprotein cholesterol (LDL-C) in homozygous familial hypercholesterolemia (HoFH) with a microsomal triglyceride transfer protein (MTP) inhibitor may reduce CV events
                              
 
                                  Event:
                                  
                                    ESC Congress 2016
                                  
 
                                  Topic:
                                  
                                    Primary cardiovascular prevention: interventions and outcomes
                                  
 
                                  Session:
                                  
                                    What's new in hereditary dyslipidaemia?